EUVIMEDEUVIMED entdecken
Crossref

Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform

Jiawei Du, Xin Chen, Xiaoxuan Xu, Ziting Que, Mengyan Zhai, Qinyanqiu Xiang, Zhiwei Zhang, Zhiqi Zhang, Yong Shao, Xue Yang, Fengqin Miao, Jianqiong Zhang und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-024-06952-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Jiawei Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Southeast University, Zh…. Hauptthemen laut MEDLINE: Immunotherapy, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Ultrasonic Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Jiangsu Funding Program for Excellent Postdoctoral Talent, National Natural Science Foundation of China, the National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Sonodynamic therapy (SDT) is a promising strategy as an "in situ vaccine" to enhance activation of antitumor immune responses in solid tumors. However, the dense extracellular matrix (ECM) in pancreatic ductal adenocarcinoma (PDAC) lead to hypoxia and limited penetration of most drugs, aggravating the immunosuppressive tumor microenvironment and limiting the efficacy of synergistic sonodynamic immunotherapy. Therefore, it is essential to regulate ECM in order to alleviate tumor hypoxia and enhance the efficacy of sonodynamic immunotherapy for PDAC. METHODS: The CPIM nanoplatform, consisting of a macrophage membrane-coated oxygen and drug delivery system (CM@PFOB-ICG-α-Mangostin), was synthesized using ultrasound and extrusion methods. The in vivo homologous targeting and hypoxia alleviation capabilities of CPIM were evaluated through near-infrared (NIR) imaging and photoacoustic (PA) imaging. The tumor growth inhibition potential and ability to reprogram the tumor microenvironment by the CPIM nanoplatform were also investigated. RESULTS: Co-delivery of α-Mangostin inhibits CAFs and enhances stromal depletion, thereby facilitating better infiltration of macromolecules. Additionally, the nanoemulsion containing perfluorocarbon (PFC) can target tumor cells and accumulate within them through homologous targeting. The US irradiation results in the rapid release of oxygen, serving as a potential source of sonodynamic therapy for hypoxic tumors. Moreover, CPIM reshapes the immunosuppressive microenvironment increasing the population of cytotoxic T lymphocytes (CTLs), and enhancing their anti-tumor immune response through the use of anti-PDL1 antibodies to block immune checkpoints. CONCLUSION: The present study offers a potential strategy for the co-delivery of oxygen and α-Mangostin, aiming to enhance the penetration of tumors to improve SDT. This approach effectively addresses the existing limitations of immune checkpoint blockade (ICB) treatment in solid tumors, while simultaneously boosting the immune response through synergistic sonodynamic immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCarcinoma, Pancreatic DuctalPancreatic NeoplasmsUltrasonic TherapyNanoparticlesCell MembraneAnimalsMiceHumansCell Line, TumorXanthonesTumor Microenvironment

Stichwörter der Autor:innen

Cancer-associated fibroblastsExtracellular matrixImmune checkpoint inhibitorsPancreatic ductal adenocarcinoma (PDAC)Sonodynamic immunotherapy

Substanzen

Xanthonesmangostin

Autor:innen und Institutionen

  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Southeast University, Zhongda Hospital, Medical School of Southeast University, 87 Dingjiaqiao…
  • Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, Southeast University, Nanjing, 210009, P.R. China.
  • Department of Microbiology and Immunology, Medical School, Southeast University, 87th DingJiaQiao Road, Nanjing, 210009, P.R. China.

ORCID-Profile: Shenghong Ju

Förderung

  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • National Natural Science Foundation of China
  • the National Key R&D Program of China
  • the Natural Science Foundation of Jiangsu Province
  • the Fundamental Research Funds for the Central Universities

Zitieren

APA

Du, J., Chen, X., Xu, X., Que, Z., Zhai, M., Xiang, Q., Zhang, Z., Zhang, Z., Shao, Y., Yang, X., Miao, F., Zhang, J., Xie, J., & Ju, S. (2025). Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06952-y

Vancouver

Du J, Chen X, Xu X, Que Z, Zhai M, Xiang Q, et al. Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06952-y

BibTeX
@article{Du2025,
  author = {Du, Jiawei and Chen, Xin and Xu, Xiaoxuan and Que, Ziting and Zhai, Mengyan and Xiang, Qinyanqiu and Zhang, Zhiwei and Zhang, Zhiqi and Shao, Yong and Yang, Xue and Miao, Fengqin and Zhang, Jianqiong and Xie, Jinbing and Ju, Shenghong},
  title = {Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-024-06952-y}
}
Kostenlos starten →